关于先锋
Company Profile
Clindamycin Phosphate for Injection
Keywords: Cardiovascular | Breathing
Category:Injection product catalog
Clindamycin Phosphate for Injection details
|
Drug generic name |
Clindamycin Phosphate for Injection |
|
dosage form |
Freeze-dried powder injection |
|
Specification |
0.3g 、0.6g 、0.9g |
|
Package |
5 00 pieces/piece |
|
Type of medical insurance |
Medicare Class A |
|
Guoyao Zhunzi |
H20153219 、H20153218 、H20153217 |
|
Manufacturer |
Anhui Pioneer Pharmaceutical Co., Ltd. |
Commodity name: Kemeifeng
Indications : This product is used to treat the following serious infections caused by sensitive bacteria:
Lower respiratory tract infection , including pneumonia , empyema, and lung abscess caused by anaerobic bacteria, Staphylococcus aureus , Streptococcus pneumoniae , other streptococci (except Enterococcus faecalis) and Staphylococcus aureus.
Skin and soft tissue infections caused by Streptococcus pyogenes , Staphylococcus aureus , and anaerobic bacteria .
Gynecological infections caused by sensitive anaerobic bacteria infection , including endometritis , non-gonococcal tubo-ovarian abscess , pelvic cellulitis , and postoperative vaginal incision infection .
Intra-abdominal infections caused by susceptible anaerobic bacteria , including peritonitis and intra-abdominal abscesses .
Sepsis caused by Staphylococcus aureus , Streptococcus (except Enterococcus), sensitive anaerobic bacteria.
Bone and joint infections caused by Staphylococcus aureus, including acute hematogenous osteomyelitis , as an adjunct to surgical treatment of chronic bone and joint infections caused by susceptible microorganisms .
In order to reduce the emergence of drug-resistant bacteria and maintain the drug resistance of clindamycin phosphate and other antibiotics , clindamycin phosphate can only be used to treat or prevent proven or extremely suspected bacterial infections . If information on bacterial culture and susceptibility is available , it should be considered when adjusting the protocol . In the absence of such data , local epidemiology and bacterial susceptibility patterns should be considered .
Related Products
在线咨询
Contact us
Add:No.35 HongFeng Road, Hefei, Anhui, China.
Tel:86-551-65355028
Fax:86-551-65355022
Email:xfcn@xfcn.com
Follow us
Copyright © 2023 Anhui Pioneer Pharmaceutical Co., Ltd 皖ICP备2020016893号 Powered by:www.300.cn SEO
86-551-65355028